• SENSEX 80,793.29
    1,483.28 (+1.87%)
  • BANKNIFTY 57,773.65
    1,860.05 (+3.33%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,900.00(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,463.60 1,013.95(%)
  • M & M
    3,282.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    785.55 1,017.90(%)
  • ICICI Bank
    1,569.30 1,501.45(%)
  • Sai Life
    1,815.55 1,697.00(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,322.95 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,100.00 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,317.75 1,611.20(%)
  • SBI
    1,019.10 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenith Drugs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92356.0
  • ISIN : INE0QWN01013
39.00 -1 (-1.39%)
  • As on 06 Nov 2026 (EOD)

  • Today’s Low

    39.00

  • Today’s High

    40.00

  • Open

    40.00

  • Perv Close

    39.55

  • 52W Low

    33.30

  • 52W High

    63.60

Key Indicators

  • P/E(TTM)

    16.25

  • Mar.Cap (₹Cr.)

    66.88

  • Div & Yield %

    0.00

  • Book Value(₹)

    42.76

  • Debt-Equity Ratio

    -1.39

  • AGM Date

    05-Nov-2026

  • EPS

    2.40

  • P/E Ratio

    16.25

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    66.88

  • RONW (%)

    24.13

  • ROCE (%)

    25.16

Score Board

  • Equity (₹ in Cr.)

    17.15

  • BV (₹)

    42.80

  • Sales( ₹ in Cr.)

    171.22

  • NP (in Cr.)

    4.12

  • NP Var(%)

    -44.0

  • Div%

    0.0

  • CPS (₹)

    5.90

  • EPS (₹)

    2.40

  • Traded Value (₹ in Lakhs)

    66.88

  • 52 Week High

    63.60

  • 52 Week Low

    33.30

  • Price BSE

    0.0

  • Price NSE

    39.00

  • Market Capital( in Cr.)

    66.88

  • P/C Ratio

    6.60

  • P/E Ratio

    16.30

  • Price Vs.BV

    2.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 183.10 147.52 146.37 114.52 91.66 81.12
Excise Duty 11.88 14.20 14.75 0.00 0.00 7.72
Net Sales 171.22 133.32 131.62 114.52 91.66 73.40
Other Income 5.10 2.61 2.12 1.24 0.95 0.11
Stock Adjustments 0.46 0.59 -1.36 0.54 2.93 -0.16
Total Income 176.78 136.52 132.38 116.30 95.54 73.35
EXPENDITURE :            
Raw Materials 60.72 52.76 36.41 0.00 75.44 47.69
Power and Fuel Cost 0.00 0.00 1.09 1.04 0.00 0.00
Employee Cost 7.47 6.76 5.34 4.96 2.98 2.41
Other Manufacturing Expenses 75.36 45.49 54.80 84.63 2.49 4.84
Selling and Administration Expenses 15.66 14.84 15.62 0.00 4.86 10.95
Miscellaneous Expenses 0.53 0.72 1.53 15.38 1.81 0.16
Employee Benefit Expenses 7.47 6.76 5.34 4.96 2.98 2.41
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 159.74 120.58 114.79 106.01 87.58 66.05
Operating Profit 17.05 15.94 17.59 10.29 7.95 7.31
Interest 5.61 3.71 3.00 2.33 2.21 1.49
Gross Profit 11.44 12.23 14.59 7.96 5.74 5.82
Depreciation 6.05 2.97 1.30 1.30 1.34 1.22
Profit Before Tax 5.39 9.26 13.29 6.66 4.40 4.60
Current Tax 1.61 2.05 3.99 1.83 1.24 1.36
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.16 0.05 -0.24 -0.05 -0.05 0.17
Reported Net Profit 3.94 7.16 9.54 4.88 3.21 3.07
Extraordinary Items -0.17 -0.19 -1.11 0.00 0.00 0.00
Adjusted Net Profit 4.11 7.35 10.65 4.88 3.21 3.07
Adjustment below Net Profit 0.00 0.00 -11.40 -4.88 0.00 0.00
P & L Balance brought forward 21.57 14.41 17.13 0.00 9.04 5.97
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.86 0.00 0.00 0.00
P & L Balance carried down 25.51 21.57 14.41 0.00 12.25 9.04
Dividend 0.00 0.00 0.86 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 5.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.50 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.30 4.18 5.56 122.03 80.32 76.66
Earnings Per Share(Adj)-Unit Curr 2.30 4.18 5.56 - - -
Book Value 42.76 40.46 36.28 443.30 321.27 240.95
Book Value(Adj)-Unit Curr 42.76 40.46 36.28 - - -

Shareholding Pattern

  • Promoter Group

    69.98%

  • Public Share Holding

    30.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,000,000 69.98 12,000,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,000,000 69.98 12,000,000 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 507,600 2.96 507,600 20
Clearing Members 93,200 0.54 93,200 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 92,000 0.54 92,000 26
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,392,000 8.12 1,392,000 17
Individuals holding nominal share capital up to Rs. 1 lakh 2,884,800 16.82 2,884,800 1,183
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 179,200 1.05 179,200 62
Sub Total 5,148,800 30.02 5,148,800 1,310
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 17,148,800 100.00 17,148,800 1,317

Company Background

Zenith Drugs LtdPharmaceuticals - Indian - Formulations

  • Zenith Drugs Ltd
  • BSE Code : 92356.0
  • ISIN : INE0QWN01013

  • Incorporation Year

    2000

  • Registered Office

    K # 72/5 Village Muradpura
    NA Depalpur, Indore,
    Madhya Pradesh-453001

  • Telephone

    +91 84355 01867

  • FAX

  • Chairman

  • Managing Director

    SANDEEP BHARDWAJ

  • Company Secretary

    Sakshi Bhawsar

  • Auditor

    VDS & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Zenith Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenith Drugs 39.00 176.32 183.10 16.96 8.92
Abbott India 26,592.70 7,217.19 6,929.05 35.00 43.78
Astrazeneca Phar 6,294.90 2,304.07 2,275.58 92.78 27.86
Glaxosmi. Pharma 2,500.70 3,932.76 3,790.20 37.16 58.17
Evonile Pharma 1,714.35 393.10 354.33 -1,058.24 15.94
Cipla 1,401.75 20,102.60 18,979.95 42.72 13.88
Bliss GVS Pharma 630.80 773.53 729.81 41.12 12.51
Amrutanjan Healt 518.60 520.13 502.55 26.17 24.16
Fermenta Biotec. 416.65 474.15 450.25 19.45 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 36.00 19.52 3.94 66.67 6.77